Endometrial Cancer Market to Grow with a CAGR of 5.23% through 2029F
Rising
prevalence of cancers are expected to drive the Global Endometrial Cancer
Market in the forecast period 2025-2029.
According
to TechSci Research report, “Endometrial Cancer Market – Global
Industry Size, Share, Trends, Competition Forecast & Opportunities,
2029F”, the Global Endometrial Cancer Market stood at USD 28.32 billion in
2023 and is anticipated to grow with a CAGR of 5.23% in the forecast period through 2029. Advancements in medical technology play a pivotal role in shaping
the Global Endometrial Cancer Market by revolutionizing the diagnosis,
treatment, and management of this cancer type. These technological
breakthroughs are instrumental in improving patient outcomes, enhancing early
detection, and refining treatment approaches. Diagnostic imaging techniques
such as magnetic resonance imaging (MRI), positron emission tomography (PET),
and computed tomography (CT) scans offer precise visualization of tumors and
help determine their size, location, and spread. This aids clinicians in
accurately staging the cancer and planning tailored treatment strategies.
Genetic
testing and molecular profiling are becoming integral components of endometrial
cancer care. They enable the identification of specific genetic alterations
associated with cancer, allowing for personalized treatment selection and
prediction of treatment response. Biomarker assays help in early detection and
prognosis assessment, aiding clinicians in making informed decisions. Minimally
invasive surgical procedures, including laparoscopy and robotic-assisted
surgery, offer reduced recovery times, less postoperative discomfort, and
improved cosmetic outcomes for patients undergoing tumor removal or
hysterectomy. Moreover, advancements in radiation therapy techniques like
intensity-modulated radiation therapy (IMRT) and stereotactic body radiation
therapy (SBRT) enable precise targeting of cancer cells while sparing healthy
tissue, minimizing side effects. In the context of endometrial cancer
treatment, medical technology's rapid evolution is driving innovation, enabling
targeted therapies and immunotherapies that specifically address cancer cells
while minimizing collateral damage to surrounding tissues. These advancements
collectively contribute to higher treatment efficacy, improved patient quality
of life, and the overall progress of the Global Endometrial Cancer Market.
Browse
over XX market data Figures spread through XX Pages and an in-depth TOC on
"Global Endometrial Cancer Market”
The
Global Endometrial Cancer Market is segmented into cancer type, therapy,
diagnosis method, end use, regional distribution and company.
Based on the diagnosis method, pelvic ultrasound is
anticipated to experience the fastest growth in the coming years. Pelvic
ultrasound offers several advantages, including non-invasiveness,
cost-effectiveness, and accessibility, making it a preferred diagnostic
modality for detecting endometrial abnormalities. The procedure involves using
high-frequency sound waves to create images of the uterus and surrounding
pelvic structures, allowing healthcare providers to evaluate the thickness of
the endometrium and identify any suspicious lesions or masses. Advancements
in ultrasound technology, such as 3D and Doppler ultrasound, enhance the
accuracy and diagnostic capabilities of pelvic ultrasound for detecting
endometrial cancer. Moreover, the increasing adoption of minimally invasive
techniques, such as trans-vaginal ultrasound, further contributes to the
widespread use of pelvic ultrasound in clinical practice. Pelvic ultrasound is
often used as a screening tool in conjunction with other diagnostic tests, such
as endometrial biopsy or hysteroscopy, to confirm or rule out the presence of
endometrial cancer. As healthcare systems focus on early detection and prevention
strategies, pelvic ultrasound is expected to play a pivotal role in the timely
diagnosis and management of endometrial cancer, driving its growth in the
diagnostic market segment.
Based on the region, North America is anticipated to
experience the fastest growth in the coming years within the global endometrial
cancer market. Several factors contribute to this projected growth, including
the region's well-established healthcare infrastructure, advanced diagnostic
and treatment technologies, and high levels of healthcare expenditure.
Additionally, increasing awareness about the importance of cancer screening and
early detection, along with favorable reimbursement policies, drives demand for
endometrial cancer diagnostic and treatment services in North America.
Also, robust research and development activities, along with the
presence of key market players and academic institutions, contribute to
innovation and advancements in the field.
Major
companies operating in Global Endometrial Cancer Market are:
- Elekta
- Karyopharm Therapeutics Inc.
- Eisai Co., Ltd
- GSK plc
- Siemens Healthineers AG
- Johnson & Johnson
- Boston Scientific Corporation
- Pfizer Inc.
- Bayer AG
- Bristol-Myers Squibb Company
Download Free Sample Report
Customers
can also request for 10% free customization on this report
“Immunotherapy
has emerged as a game-changer in cancer treatment, including endometrial
cancer. Immune checkpoint inhibitors, such as pembrolizumab and nivolumab, have
demonstrated significant clinical benefits in a subset of endometrial cancer
patients with microsatellite instability-high (MSI-H) or mismatch
repair-deficient (dMMR) tumors. Ongoing research is focused on identifying
predictive biomarkers and combination strategies to enhance the efficacy of
immunotherapy in endometrial cancer and thereby contribute to foster the demand
for Global Endometrial Cancer Market in the forecast period” said Mr. Karan
Chechi, Research Director of TechSci Research, a research-based management
consulting firm.
“Endometrial Cancer Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Cancer Type (Endometrial Carcinoma, Uterine Sarcomas), By Therapy (Immunotherapy, Radiation Therapy, Chemotherapy, Other Types of Therapies), By Diagnosis Method (Biopsy, Pelvic Ultrasound, Hysteroscopy, CT scan, Other Diagnosis Methods), By End Use (Hospitals, Imaging Centers, Others), By Region and Competition, 2019-2029F”, has
evaluated the future growth potential of Global Endometrial Cancer Market and
provides statistics & information on market size, structure and future
market growth. The report intends to provide cutting-edge market intelligence
and help decision makers take sound investment decisions. Besides, the report
also identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in Global Endometrial Cancer Market.
Contact
TechSci
Research LLC
420
Lexington Avenue,
Suite
300, New York,
United
States- 10170
M:
+13322586602
Email: [email protected]
Website: https://www.techsciresearch.com